Pancreatic ductal adenocarcinoma is an aggressive cancer that interacts with stromal cells to produce a highly inflammatory tumor microenvironment that promotes tumor growth and invasiveness. The precise interplay between tumor and stroma remains poorly understood. TLRs mediate interactions between environmental stimuli and innate immunity and trigger proinflammatory signaling cascades. Our finding that TLR7 expression is upregulated in both epithelial and stromal compartments in human and murine pancreatic cancer led us to postulate that carcinogenesis is dependent on TLR7 signaling. In a mouse model of pancreatic cancer, TLR7 ligation vigorously accelerated tumor progression and induced loss of expression of PTEN, p16, and cyclin D1 and upregulation of p21, p27, p53, c-Myc, SHPTP1, TGF-β, PPARγ, and cyclin B1. Furthermore, TLR7 ligation induced STAT3 activation and interfaced with Notch as well as canonical NF-κB and MAP kinase pathways, but downregulated expression of Notch target genes. Moreover, blockade of TLR7 protected against carcinogenesis. Since pancreatic tumorigenesis requires stromal expansion, we proposed that TLR7 ligation modulates pancreatic cancer by driving stromal inflammation. Accordingly, we found that mice lacking TLR7 exclusively within their inflammatory cells were protected from neoplasia. These data suggest that targeting TLR7 holds promise for treatment of human pancreatic cancer.
Atsuo Ochi, Christopher S. Graffeo, Constantinos P. Zambirinis, Adeel Rehman, Michael Hackman, Nina Fallon, Rocky M. Barilla, Justin R. Henning, Mohsin Jamal, Raghavendra Rao, Stephanie Greco, Michael Deutsch, Marco V. Medina-Zea, Usama Bin Saeed, Melvin O. Ego-Osuala, Cristina Hajdu, George Miller
Title and authors | Publication | Year |
---|---|---|
Dendritic cell-derived MYD88 potentiates as a biomarker for immune regulation in hepatocellular carcinoma and may predict a better immunological result
Liu Z, Zhu H, Zhang F, Huang W, Zhu S, He S, Yao Y, Song Q, Zhang X |
Frontiers in Cell and Developmental Biology | 2025 |
Involvement of nucleic acid-sensing toll-like receptors in human diseases and their controlling mechanisms
Lin YS, Chang YC, Pu TY, Chuang TH, Hsu LC |
Journal of Biomedical Science | 2025 |
TLR2 and TLR9 Blockade Using Specific Intrabodies Inhibits Inflammation-Mediated Pancreatic Cancer Cell Growth.
Ajay AK, Gasser M, Hsiao LL, Böldicke T, Waaga-Gasser AM |
2024 | |
Gut microbiota and pancreatic cancer risk, and the mediating role of immune cells and inflammatory cytokines: a Mendelian randomization study.
Chen Z, Wang Z, Bao H, Ma S |
Frontiers in immunology | 2024 |
Impact of TLR9 and TLR7 gene polymorphisms on prognosis and survival of patients with oral squamous cell carcinoma
Obrenović M, Šupić G, Miyabe S, Mladenović I, Kozomara R, Jović S, Ćurčin AP, Štefik D, Stosić S, Ðurđević BV |
Biomolecules and Biomedicine | 2024 |
Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review.
Ruze R, Song J, Yin X, Chen Y, Xu R, Wang C, Zhao Y |
Signal Transduction and Targeted Therapy | 2023 |
Dissecting the role of toll-like receptor 7 in pancreatic cancer.
Stark M, Nicolai M, Tatura M, Keber CU, Kaufmann A, Chung HR, Slater EP, Heeschen C, Lawlor RT, Scarpa A, Bartsch DK, Gress TM, Bauer S, Buchholz M |
Cancer Medicine | 2023 |
Harnessing the Microbiome to Reduce Pancreatic Cancer Burden
Bastos AR, Pereira-Marques J, Ferreira RM, Figueiredo C |
Cancers | 2023 |
Functional reprogramming of peripheral blood monocytes by soluble mediators in patients with pancreatic cancer and intraductal papillary mucinous neoplasms
Eckhoff AM, Brown MC, Landa K, Naqvi I, Holl EK, Boczkowski D, Fletcher A, Rhodin KE, Giang MH, Sullenger B, Beasley GM, Allen PJ, Nair SK |
Frontiers in immunology | 2023 |
Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives
Mukherjee S, Patra R, Behzadi P, Masotti A, Paolini A, Sarshar M |
Frontiers in immunology | 2023 |
Identification and validation of FPR1, FPR2, IL17RA and TLR7 as immunogenic cell death related genes in osteoarthritis
Ren T, Yin N, Du L, Pan M, Ding L |
Scientific Reports | 2023 |
Robinin inhibits pancreatic cancer cell proliferation, EMT and inflammation via regulating TLR2-PI3k-AKT signaling pathway.
Zhang W, Liu W, Hu X |
Cancer Cell International | 2023 |
Context-dependent functions of pattern recognition receptors in cancer
S Man, B Jenkins |
Nature Reviews Cancer | 2022 |
Potential Roles of the Gut Microbiota in Pancreatic Carcinogenesis and Therapeutics
Q Yang, J Zhang, Y Zhu |
Frontiers in Cellular and Infection Microbiology | 2022 |
The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy
A Nurmi, J Hagström, H Mustonen, H Seppänen, C Haglund, G Patel |
PloS one | 2022 |
The antitumoral activity of TLR7 ligands is corrupted by the microenvironment of pancreatic tumors
M Rouanet, N Hanoun, H Lulka, C Ferreira, P Garcin, M Sramek, G Jacquemin, A Coste, D Pagan, C Valle, E Sarot, V Pancaldi, F Lopez, L Buscail, P Cordelier |
Molecular Therapy | 2022 |
Exploration of the System-Level Mechanisms of the Herbal Drug FDY003 for Pancreatic Cancer Treatment: A Network Pharmacological Investigation
H Lee, I Lee, K Kang, S Park, M Jung, S Yang, T Kwon, D Lee, C Kuo |
Evidence-Based Complementary and Alternative Medicine | 2022 |
TLR/WNT: A Novel Relationship in Immunomodulation of Lung Cancer
Martín-Medina A, Cerón-Pisa N, Martinez-Font E, Shafiek H, Obrador-Hevia A, Sauleda J, Iglesias A |
International journal of molecular sciences | 2022 |
Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression
Giurini EF, Madonna MB, Zloza A, Gupta KH |
Cancers | 2022 |
Complex Role of Microbiome in Pancreatic Tumorigenesis: Potential Therapeutic Implications
Amara S, Yang LV, Tiriveedhi V, Muzaffar M |
Cells | 2022 |
The role of toll-like receptors (TLRs) in pan-cancer
Huang R, Sun Z, Xian S, Song D, Chang Z, Yan P, Zhang J, Yin H, Zheng Z, Hu P, Li Z, Huang D, Liu Y, Jiang C, Li M, Li S, Meng T, Yang D, Huang Z |
Annals of Medicine | 2022 |
Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer
Ye J, Mills BN, Qin SS, Garrett-Larsen J, Murphy JD, Uccello TP, Han BJ, Vrooman TG, Johnston CJ, Lord EM, Belt BA, Linehan DC, Gerber SA |
Journal for ImmunoTherapy of Cancer | 2022 |
IRAK4 signaling drives resistance to checkpoint immunotherapy in pancreatic ductal adenocarcinoma
Somani V, Zhang D, Dodhiawala PB, Lander VE, Liu X, Kang LI, Chen HP, Knolhoff BL, Li L, Grierson PM, Ruzinova MB, DeNardo DG, Lim KH |
Gastroenterology | 2022 |
The Oncobiome in Gastroenteric and Genitourinary Cancers.
D'Antonio DL, Marchetti S, Pignatelli P, Piattelli A, Curia MC |
International journal of molecular sciences | 2022 |
The Role of the Microbiome in Pancreatic Cancer
Miyabayashi K, Ijichi H, Fujishiro M |
Cancers | 2022 |
Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
Sun H, Li Y, Zhang P, Xing H, Zhao S, Song Y, Wan D, Yu J |
Biomarker Research | 2022 |
Whole-genome identification and construction of the lncRNA-mRNA co-expression network in patients with actinic keratosis
Luan C, Jin S, Hu Y, Zhou X, Liu L, Li R, Ju M, Huang D, Chen K |
Translational cancer research | 2022 |
Microbiota in the Natural History of Pancreatic Cancer: From Predisposition to Therapy
Binda C, Gibiino G, Sbrancia M, Coluccio C, Cazzato M, Carloni L, Cucchetti A, Ercolani G, Sambri V, Fabbri C |
Cancers | 2022 |
Inhibition of TLR7 and TLR9 Reduces Human Cholangiocarcinoma Cell Proliferation and Tumor Development
FE Mohamed, R Jalan, S Minogue, F Andreola, A Habtesion, A Hall, A Winstanley, SO Damink, M Malagó, N Davies, TV Luong, A Dhillon, R Mookerjee, D Dhar, RM Al-Jehani |
Digestive Diseases and Sciences | 2021 |
Role of the TRP Channels in Pancreatic Ductal Adenocarcinoma Development and Progression
G Mesquita, N Prevarskaya, A Schwab, V Lehenkyi |
Cells | 2021 |
A Combined TLR7/TLR9/GATA3 Score Can Predict Prognosis in Biliary Tract Cancer
V Branchi, L Esser, C Boden, A Jafari, J Henn, P Lingohr, MA Gonzalez-Carmona, M Schmitz, TJ Weismüller, CP Strassburg, S Manekeller, G Kristiansen, JC Kalff, H Matthaei, MI Toma |
Diagnostics | 2021 |
TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155
J Guo, M Liao, J Wang |
Cell Communication and Signaling | 2021 |
Immunohistochemical Analysis of Toll-Like Receptors, MyD88, and TRIF in Human Papillary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma
Y Nihon-Yanagi, M Wakayama, N Tochigi, F Saito, H Ogata, K Shibuya, A Mishra |
Journal of Thyroid Research | 2021 |
Micro- and Mycobiota Dysbiosis in Pancreatic Ductal Adenocarcinoma Development
R Bellotti, C Speth, TE Adolph, C Lass-Flörl, M Effenberger, D Öfner, M Maglione |
Cancers | 2021 |
Signal‐transducing innate receptors in tumor immunity
S Hangai, Y Kimura, T Taniguchi, H Yanai |
Cancer Science | 2021 |
TLR2 activation promotes tumour growth and associates with patient survival and chemotherapy response in pancreatic ductal adenocarcinoma
J Lundy, LJ Gearing, H Gao, AC West, L McLeod, V Deswaerte, L Yu, S Porazinski, M Pajic, PJ Hertzog, D Croagh, BJ Jenkins |
Oncogene | 2021 |
The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies?
G Brandi, S Turroni, F McAllister, G Frega |
International journal of molecular sciences | 2021 |
The Microbiome as a Potential Target for Therapeutic Manipulation in Pancreatic Cancer
RA Rahman, A Lamarca, RA Hubner, JW Valle, MG McNamara |
Cancers | 2021 |
Apoptosis in the Pancreatic Cancer Tumor Microenvironment—The Double-Edged Sword of Cancer-Associated Fibroblasts
E Pfeifer, JM Burchell, F Dazzi, D Sarker, R Beatson |
Cells | 2021 |
Emerging immunological strategies: recent advances and future directions
H Zhao, F Luo, J Xue, S Li, RH Xu |
Frontiers of Medicine | 2021 |
The Role of Toll-like Receptors (TLRs) Mediated Inflammation in Pancreatic Cancer Pathophysiology
A Orlacchio, P Mazzone |
International journal of molecular sciences | 2021 |
Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes
C Patinote, NB Karroum, G Moarbess, N Cirnat, I Kassab, PA Bonnet, C Deleuze-Masquéfa |
European Journal of Medicinal Chemistry | 2020 |
Clinical and Pre-Clinical Evidence of Carbonic Anhydrase IX in Pancreatic Cancer and Its High Expression in Pre-Cancerous Lesions
S Strapcova, M Takacova, L Csaderova, P Martinelli, L Lukacikova, V Gal, J Kopacek, E Svastova |
Cancers | 2020 |
Overview of the STAT‑3 signaling pathway in cancer and the development of specific inhibitors (Review)
Y Gu, I Mohammad, Z Liu |
Oncology Letters | 2020 |
Deciphering the Role of Innate Immune NF-ĸB Pathway in Pancreatic Cancer
N Khurana, PB Dodhiawala, A Bulle, KH Lim |
Cancers | 2020 |
Gut Microbiota: Its Potential Roles in Pancreatic Cancer
Q Li, M Jin, Y Liu, L Jin |
Frontiers in Cellular and Infection Microbiology | 2020 |
Ion Channel Signature in Healthy Pancreas and Pancreatic Ductal Adenocarcinoma
J Schnipper, I Dhennin-Duthille, A Ahidouch, H Ouadid-Ahidouch |
Frontiers in pharmacology | 2020 |
A prospective evaluation of serum methionine‐related metabolites in relation to pancreatic cancer risk in two prospective cohort studies
JY Huang, HN Luu, LM Butler, Ø Midttun, A Ulvik, R Wang, A Jin, YT Gao, Y Tan, PM Ueland, WP Koh, JM Yuan |
International Journal of Cancer | 2020 |
Gut microbiota in pancreatic diseases: possible new therapeutic strategies
L Pan, B Li, X Pan, J Sun |
Acta Pharmacologica Sinica | 2020 |
Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities
VP Balachandran, GL Beatty, SK Dougan |
Gastroenterology | 2019 |
Obesity-Induced Adipose Tissue Inflammation as a Strong Promotional Factor for Pancreatic Ductal Adenocarcinoma
HH Chang, G Eibl |
Cells | 2019 |
Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis
D Thomas, P Radhakrishnan |
Molecular Cancer | 2019 |
The microbiota and microbiome in pancreatic cancer: more influential than expected
MY Wei, S Shi, C Liang, QC Meng, J Hua, YY Zhang, J Liu, B Zhang, J Xu, XJ Yu |
Molecular Cancer | 2019 |
Role of the microbiome in occurrence, development and treatment of pancreatic cancer
Y Wang, G Yang, L You, J Yang, M Feng, J Qiu, F Zhao, Y Liu, Z Cao, L Zheng, T Zhang, Y Zhao |
Molecular Cancer | 2019 |
Cellular determinants and therapeutic implications of inflammation in pancreatic cancer
ML Stone, GL Beatty |
Pharmacology & Therapeutics | 2019 |
Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer
M Lanki, H Seppänen, H Mustonen, J Hagström, C Haglund, F Canzian |
PloS one | 2019 |
Persistent Toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance
KA Michaelis, MA Norgard, PR Levasseur, B Olson, KG Burfeind, AC Buenafe, X Zhu, S Jeng, SK McWeeney, DL Marks |
Brain, Behavior, and Immunity | 2019 |
Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders
D Pagliari, A Saviano, EE Newton, ML Serricchio, AA Lago, A Gasbarrini, R Cianci |
Mediators of Inflammation | 2018 |
Small Molecules Drive Big Improvements in Immuno-Oncology Therapies
BR Huck, L Kötzner, K Urbahns |
Angewandte Chemie (International ed. in English) | 2018 |
Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist
T Hosoya, F Sato-Kaneko, A Ahmadi, S Yao, F Lao, K Kitaura, T Matsutani, DA Carson, T Hayashi |
Proceedings of the National Academy of Sciences | 2018 |
Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells
M Dajon, K Iribarren, F Petitprez, S Marmier, A Lupo, M Gillard, H Ouakrim, N Victor, DB Vincenzo, PE Joubert, O Kepp, G Kroemer, M Alifano, D Damotte, I Cremer |
OncoImmunology | 2018 |
Human Gut Microbiota and Gastrointestinal Cancer
C Meng, C Bai, TD Brown, LE Hood, Q Tian |
Genomics, proteomics & bioinformatics / Beijing Genomics Institute | 2018 |
A Novel Interaction Between the TLR7 and a Colchicine Derivative Revealed Through a Computational and Experimental Study
F Gentile, M Deriu, K Barakat, A Danani, J Tuszynski |
Pharmaceuticals (Basel, Switzerland) | 2018 |
Radiation and Local Anti-CD40 Generate an Effective in situ Vaccine in Preclinical Models of Pancreatic Cancer
S Yasmin-Karim, PT Bruck, M Moreau, S Kunjachan, GZ Chen, R Kumar, S Grabow, SK Dougan, W Ngwa |
Frontiers in immunology | 2018 |
Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes
A Solovyov, N Vabret, KS Arora, A Snyder, SA Funt, DF Bajorin, JE Rosenberg, N Bhardwaj, DT Ting, BD Greenbaum |
Cell Reports | 2018 |
TRPM2 promotes the proliferation and invasion of pancreatic ductal adenocarcinoma
R Lin, Y Wang, Q Chen, Z Liu, S Xiao, B Wang, B Shi |
Molecular medicine reports | 2018 |
Tumor–Stroma IL1β-IRAK4 Feedforward Circuitry Drives Tumor Fibrosis, Chemoresistance, and Poor Prognosis in Pancreatic Cancer
D Zhang, L Li, H Jiang, Q Li, A Wang-Gillam, J Yu, R Head, J Liu, MB Ruzinova, KH Lim |
Cancer research | 2018 |
ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling
AV Pinho, MV Bulck, L Chantrill, M Arshi, T Sklyarova, D Herrmann, C Vennin, D Gallego-Ortega, A Mawson, M Giry-Laterriere, A Magenau, G Leuckx, L Baeyens, AJ Gill, P Phillips, P Timpson, AV Biankin, J Wu, I Rooman |
Nature Communications | 2018 |
Inflammation and de-differentiation in pancreatic carcinogenesis
T Seimiya, M Otsuka, T Iwata, E Tanaka, T Suzuki, K Sekiba, M Yamagami, R Ishibashi, K Koike |
World journal of clinical cases | 2018 |
Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer
CP Zambirinis, G Miller |
Trends in Molecular Medicine | 2017 |
Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth
JC Klein, K Moses, G Zelinskyy, S Sody, J Buer, S Lang, I Helfrich, U Dittmer, CJ Kirschning, S Brandau |
Nature Communications | 2017 |
Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer: Predictive value of TLR7 polymorphism for cetuximab
S Okazaki, S Stintzing, Y Sunakawa, S Cao, W Zhang, D Yang, Y Ning, S Matsusaka, MD Berger, Y Miyamoto, M Suenaga, M Schirripa, JD West, R Gopez, T Akihito, W Ichikawa, V Heinemann, RW DePaolo, HJ Lenz |
International Journal of Cancer | 2017 |
Toll-like receptors 7 and 8 expression correlates with the expression of immune biomarkers and positively predicts the clinical outcome of patients with melanoma
M Zhang, Z Yan, J Wang, X Yao |
OncoTargets and therapy | 2017 |
Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance
D Daley, VR Mani, N Mohan, N Akkad, A Ochi, DW Heindel, KB Lee, CP Zambirinis, GS Pandian, S Savadkar, A Torres-Hernandez, S Nayak, D Wang, M Hundeyin, B Diskin, B Aykut, G Werba, RM Barilla, R Rodriguez, S Chang, L Gardner, LK Mahal, B Ueberheide, G Miller |
Nature Medicine | 2017 |
NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma
D Daley, VR Mani, N Mohan, N Akkad, GS Pandian, S Savadkar, KB Lee, A Torres-Hernandez, B Aykut, B Diskin, W Wang, MS Farooq, AI Mahmud, G Werba, EJ Morales, S Lall, BJ Wadowski, AG Rubin, ME Berman, R Narayanan, M Hundeyin, G Miller |
Journal of Experimental Medicine | 2017 |
PD‑L1 expression is associated with p16INK4A expression in non‑oropharyngeal head and neck squamous cell carcinoma
SC Chen, P Chang, HJ Wang, SK Tai, PY Chu, MH Yang |
Oncology Letters | 2017 |
γδ T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation
D Daley, CP Zambirinis, L Seifert, N Akkad, N Mohan, G Werba, R Barilla, A Torres-Hernandez, M Hundeyin, VR Mani, A Avanzi, D Tippens, R Narayanan, JE Jang, E Newman, VG Pillarisetty, ML Dustin, D Bar-Sagi, C Hajdu, G Miller |
Cell | 2016 |
Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice
L Seifert, G Werba, S Tiwari, NN Ly, S Nguy, S Alothman, D Alqunaibit, A Avanzi, D Daley, R Barilla, D Tippens, A Torres-Hernandez, M Hundeyin, VR Mani, C Hajdu, I Pellicciotta, P Oh, K Du, G Miller |
Gastroenterology | 2016 |
Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma
D Zhang, L Li, H Jiang, BL Knolhoff, AC Lockhart, A Wang-Gillam, DG DeNardo, MB Ruzinova, KH Lim |
Clinical cancer research | 2016 |
Interplay between Inflammation and Stemness in Cancer Cells: The Role of Toll-Like Receptor Signaling
DW Yeh, LR Huang, YW Chen, CY Huang, TH Chuang |
Journal of Immunology Research | 2016 |
Application potential of toll-like receptors in cancer immunotherapy: Systematic review
M Shi, X Chen, K Ye, Y Yao, Y Li |
Medicine | 2016 |
Targeting inflammation in pancreatic cancer: Clinical translation
Colin William Steele, Nina Angharad Kaur Gill, Nigel Balfour Jamieson, Christopher Ross Carter |
World journal of gastrointestinal oncology | 2016 |
Dysregulation of signaling pathways associated with innate antibacterial immunity in patients with pancreatic cancer
R Słotwiński, SM Słotwińska |
CENT EUR J IMMUNOL | 2016 |
The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression
L Seifert, G Werba, S Tiwari, NN Ly, S Alothman, D Alqunaibit, A Avanzi, R Barilla, D Daley, SH Greco, A Torres-Hernandez, M Pergamo, A Ochi, CP Zambirinis, M Pansari, M Rendon, D Tippens, M Hundeyin, VR Mani, C Hajdu, D Engle, G Miller |
Nature | 2016 |
Lipid rafts promote liver cancer cell proliferation and migration by up-regulation of TLR7 expression
Y Liu, X Guo, L Wu, M Yang, Z Li, Y Gao, S Liu, G Zhou, J Zhao |
Oncotarget | 2016 |
Pattern Recognition Receptors in Cancer Progression and Metastasis
B Dwarakanath, S Pandey, S Singh, AN Bhatt, K Natarajan, V Anang |
Cancer Growth and Metastasis | 2015 |
Dual roles of TLR7 in the lung cancer microenvironment
M Dajon, K Irribarren, I Cremer |
OncoImmunology | 2015 |
Radiation takes its Toll
JA Ratikan, ED Micewicz, MW Xie, D Schaue |
Cancer Letters | 2015 |
TLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer
T Grimmig, N Matthes, K Hoeland, S Tripathi, A Chandraker, M Grimm, R Moench, EM Moll, H Friess, I Tsaur, R Blaheta, C Germer, A Waaga-Gasser, M Gasser |
International journal of oncology | 2015 |
Dectin-1 Regulates Hepatic Fibrosis and Hepatocarcinogenesis by Suppressing TLR4 Signaling Pathways
L Seifert, M Deutsch, S Alothman, D Alqunaibit, G Werba, M Pansari, M Pergamo, A Ochi, A Torres-Hernandez, E Levie, D Tippens, SH Greco, S Tiwari, NN Ly, A Eisenthal, E van Heerden, A Avanzi, R Barilla, CP Zambirinis, M Rendon, D Daley, HL Pachter, C Hajdu, G Miller |
Cell Reports | 2015 |
Roles of Commensal Microbiota in Pancreas Homeostasis and Pancreatic Pathologies
C Leal-Lopes, FJ Velloso, JC Campopiano, MC Sogayar, RG Correa |
Journal of Diabetes Research | 2015 |
TGF-β Blockade Reduces Mortality and Metabolic Changes in a Validated Murine Model of Pancreatic Cancer Cachexia
SH Greco, L Tomkötter, AK Vahle, R Rokosh, A Avanzi, SK Mahmood, M Deutsch, S Alothman, D Alqunaibit, A Ochi, C Zambirinis, T Mohaimin, M Rendon, E Levie, M Pansari, A Torres-Hernandez, D Daley, R Barilla, HL Pachter, D Tippens, H Malik, A Boutajangout, T Wisniewski, G Miller, AP Singh |
PloS one | 2015 |
TLR9 ligation in pancreatic stellate cells promotes tumorigenesis
CP Zambirinis, E Levie, S Nguy, A Avanzi, R Barilla, Y Xu, L Seifert, D Daley, SH Greco, M Deutsch, S Jonnadula, A Torres-Hernandez, D Tippens, S Pushalkar, A Eisenthal, D Saxena, J Ahn, C Hajdu, DD Engle, D Tuveson, G Miller |
Journal of Experimental Medicine | 2015 |
Structure Based Modeling of Small Molecules Binding to the TLR7 by Atomistic Level Simulations
F Gentile, M Deriu, G Licandro, A Prunotto, A Danani, J Tuszynski |
Molecules (Basel, Switzerland) | 2015 |
Multiple regulation pathways and pivotal biological functions of STAT3 in cancer
J Yuan, F Zhang, R Niu |
Scientific Reports | 2015 |
Radiotherapy combined with TLR7/8 activation induces strong immune responses against gastrointestinal tumors.
Schölch S, Rauber C, Tietz A, Rahbari NN, Bork U, Schmidt T, Kahlert C, Haberkorn U, Tomai MA, Lipson KE, Carretero R, Weitz J, Koch M, Huber PE |
Oncotarget | 2015 |
Regulation and function of signal transducer and activator of transcription 3
QR Qi, ZM Yang |
World journal of biological chemistry | 2014 |
Pancreatic Cancer, Inflammation, and Microbiome:
CP Zambirinis, S Pushalkar, D Saxena, G Miller |
The Cancer Journal | 2014 |
Revisiting STAT3 signalling in cancer: new and unexpected biological functions
H Yu, H Lee, A Herrmann, R Buettner, R Jove |
Nature Reviews Cancer | 2014 |
Interleukin 17-Producing γδT Cells Promote Hepatic Regeneration in Mice
R Rao, CS Graffeo, R Gulati, M Jamal, S Narayan, C Zambirinis, R Barilla, M Deutsch, S Greco, A Ochi, L Tomkötter, R Blobstein, A Avanzi, DM Tippens, Y Gelbstein, EV Heerden, G Miller |
Gastroenterology | 2014 |
Clinical immunology Gene expression disorders of innate antibacterial signaling pathway in pancreatic cancer patients: implications for leukocyte dysfunction and tumor progression
R Słotwiński, A Dąbrowska, G Lech, M Słodkowski, SM Słotwińska |
CENT EUR J IMMUNOL | 2014 |
Intervention on toll-like receptors in pancreatic cancer
J Vaz, R Andersson |
World journal of gastroenterology : WJG | 2014 |
Spontaneous Mesotheliomas in F344/N Rats Are Characterized by Dysregulation of Cellular Growth and Immune Function Pathways
PE Blackshear, AR Pandiri, TV Ton, NP Clayton, KR Shockley, SD Peddada, KE Gerrish, RC Sills, MJ Hoenerhoff |
Toxicologic pathology | 2013 |
The Yin and Yang of Toll-like receptors in cancer
JP Pradere, DH Dapito, RF Schwabe |
Oncogene | 2013 |
Exploiting inflammation for therapeutic gain in pancreatic cancer
CW Steele, NB Jamieson, TR Evans, CJ McKay, OJ Sansom, JP Morton, CR Carter |
British Journal of Cancer | 2013 |
Role of bacterial infections in pancreatic cancer
DS Michaud |
Carcinogenesis | 2013 |
Induction of TRIF- or MYD88-dependent pathways perturbs cell cycle regulation in pancreatic cancer
CP Zambirinis, A Ochi, R Barilla, S Greco, M Deutsch, G Miller |
Cell cycle (Georgetown, Tex.) | 2013 |
Signaling via MYD88 in the pancreatic tumor microenvironment: A double-edged sword
CP Zambirinis, G Miller |
OncoImmunology | 2013 |
The activation of TLR7 regulates the expression of VEGF, TIMP1, MMP2, IL-6, and IL-15 in Hela cells
L Li, FW Cheng, F Wang, B Jia, X Luo, SQ Zhang |
Molecular and Cellular Biochemistry | 2013 |
Trial Watch
E Vacchelli, A Eggermont, C Sautès-Fridman, J Galon, L Zitvogel, G Kroemer, L Galluzzi |
OncoImmunology | 2013 |
Angiogenic gene signature in human pancreatic cancer correlates with TGF-beta and inflammatory transcriptomes
KE Craven, J Gore, JL Wilson, M Korc |
Oncotarget | 2010 |
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |